Global Theranostics Market

Nisha Shaha22 Mar, 2022Health

Global Theranostic Market accounted for US$ 81.40 billion in 2020 and is estimated to be US$ 468.7 billion by 2030 and is anticipated to register a CAGR of 10.40%. Theranostics is referred to the fusion of diagnostics and drug therapy. It involves nanoscience to unite diagnostic and therapeutic applications to form a single agent, allowing for diagnosis, drug delivery, and treatment response monitoring. Theranostics helps in optimizing safety, effective results, and streamlining of drug development. It uses specific biological pathways in human body to acquire diagnostic images as well as to deliver a therapeutic dose of radiation to the patient. Further, the theranostics uses specific biological pathways in the human body, to acquire diagnostic images and also to deliver a therapeutic dose of radiation to the patient.